Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.

Filippi M, Rocca MA, Pagani E, De Stefano N, Jeffery D, Kappos L, Montalban X, Boyko AN, Comi G; ALLEGRO Study Group.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):851-8. doi: 10.1136/jnnp-2013-306132. Epub 2013 Sep 12.

PMID:
24029546
[PubMed - in process]
2.

Placebo-controlled trial of oral laquinimod for multiple sclerosis.

Comi G, Jeffery D, Kappos L, Montalban X, Boyko A, Rocca MA, Filippi M; ALLEGRO Study Group.

N Engl J Med. 2012 Mar 15;366(11):1000-9. doi: 10.1056/NEJMoa1104318.

PMID:
22417253
[PubMed - indexed for MEDLINE]
Free Article
3.

Prevalence of CCR5-tropic HIV-1 among treatment-experienced individuals in Spain.

Moreno, Clotet, Sarría, Ortega, Leal, Rodriguez-Arrondo, Sánchez-de la Rosa; Allegro Study Group.

HIV Clin Trials. 2009 Nov-Dec;10(6):394-402. doi: 10.1310/hct1006-394.

PMID:
20133270
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk